{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:24:39Z","timestamp":1790954679714,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["97-01-106-19371"],"award-info":[{"award-number":["97-01-106-19371"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systematic candidemia studies, especially in southern Iran, are scarce. In the current prospective study, we investigated candidemia in three major healthcare centers of Shiraz, the largest city in southern Iran. Yeast isolates from blood and other sterile body fluids were identified by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry and subjected to antifungal susceptibility testing (AFST) using the broth microdilution method. Clinical data were retrieved from patients\u2019 medical records. In total, 113 yeast isolates were recovered from 109 patients, over 60% of whom received fluconazole. Antifungal drugs were prescribed without considering species identification or AFST. The all-cause mortality rate was 28%. Almost 30% of the patients were from intensive care units (ICUs). Candida albicans (56\/113; 49.5%) was the most prevalent species followed by C. glabrata (26\/113; 23%), C. parapsilosis (13\/113; 11.5%), C. tropicalis (7\/113; 6.2%), and C. dubliniensis (5\/113; 4.4%). Only five isolates showed antifungal resistance or decreased susceptibility to fluconazole: one C. orthopsilosis isolate from an azole-na\u00efve patient and two C. glabrata, one C. albicans, and one C. dubliniensis isolates from patients treated with azoles, who developed therapeutic failure against azoles later. Our results revealed a low level of antifungal resistance but a notable rate of azole therapeutic failure among patients with candidemia due to non-albicans Candida species, which threaten the efficacy of fluconazole, the most widely used antifungal in southern regions of Iran. Candidemia studies should not be confined to ICUs and treatment should be administered based on species identification and AFST results.<\/jats:p>","DOI":"10.1093\/mmy\/myaa059","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T03:54:27Z","timestamp":1594871667000},"page":"422-430","source":"Crossref","is-referenced-by-count":27,"title":["Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016\u20132018)"],"prefix":"10.1093","volume":"59","author":[{"given":"Amir","family":"Arastehfar","sequence":"first","affiliation":[{"name":"Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA"},{"name":"Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Yazdanpanah","sequence":"additional","affiliation":[{"name":"Basic Sciences in Infectious Diseases Research Center, & Department of Medical Mycology & Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Bakhtiari","sequence":"additional","affiliation":[{"name":"Basic Sciences in Infectious Diseases Research Center, & Department of Medical Mycology & Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Fang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory Molecular Medical Mycology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Pan","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory Molecular Medical Mycology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0421-8659","authenticated-orcid":false,"given":"Shahram","family":"Mahmoudi","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Pakshir","sequence":"additional","affiliation":[{"name":"Basic Sciences in Infectious Diseases Research Center, & Department of Medical Mycology & Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Daneshnia","sequence":"additional","affiliation":[{"name":"Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun","family":"Boekhout","sequence":"additional","affiliation":[{"name":"Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands"},{"name":"Shanghai Key Laboratory Molecular Medical Mycology, Shanghai, China"},{"name":"Institute of Biodiversity and Ecosystems Dynamics (IBED, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1174-4182","authenticated-orcid":false,"given":"Macit","family":"Ilkit","sequence":"additional","affiliation":[{"name":"Division of Mycology, Department of Microbiology, Faculty of Medicine, University of \u00c7ukurova, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Perlin","sequence":"additional","affiliation":[{"name":"Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamiar","family":"Zomorodian","sequence":"additional","affiliation":[{"name":"Basic Sciences in Infectious Diseases Research Center, & Department of Medical Mycology & Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"},{"name":"Department of Medical Mycology and Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Zand","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"},{"name":"Shiraz Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"2021050323561757500_bib1","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"2021050323561757500_bib2","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021050323561757500_bib3","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2021050323561757500_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13104","article-title":"Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure","author":"Arastehfar","year":"2020","journal-title":"Mycoses."},{"key":"2021050323561757500_bib5","article-title":"First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey","author":"Arastehfar","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050323561757500_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13756-020-00710-z","article-title":"Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures","volume":"9","author":"Megri","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"2021050323561757500_bib7","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.3390\/jof4030105","article-title":"Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata","volume":"4","author":"Healey","year":"2018","journal-title":"J Fungi"},{"key":"2021050323561757500_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","article-title":"Incidence, characteristics and outcome of ICU-acquired candidemia in India","volume":"41","author":"Chakrabarti","year":"2015","journal-title":"Intensive Care Med"},{"key":"2021050323561757500_bib9","article-title":"Genetically-related micafungin-resistant C. parapsilosis blood isolates harboring a novel mutation R658G in hotspot1-Fks1p: A new challenge","author":"Arastehfar"},{"key":"2021050323561757500_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fcimb.2020.00206","article-title":"Evaluation of molecular epidemiology, clinical characteristics, antifungal susceptibility profiles, and molecular mechanisms of antifungal resistance of Iranian Candida parapsilosis species complex blood isolates","volume":"10","author":"Arastehfar","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2021050323561757500_bib11","doi-asserted-by":"crossref","article-title":"The quiet and underappreciated rise of drug resistant invasive fungal pathogens","author":"Arastehfar","DOI":"10.3390\/jof6030138"},{"key":"2021050323561757500_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/jof5040090","article-title":"Identification of mycoses in developing countries","volume":"5","author":"Arastehfar","year":"2019","journal-title":"J Fungi"},{"key":"2021050323561757500_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/myc.12698","article-title":"Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran","volume":"61","author":"Charsizadeh","year":"2018","journal-title":"Mycoses"},{"key":"2021050323561757500_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1099\/jmm.0.001189","article-title":"Epidemiology of yeast species causing bloodstream infection in Tehran, Iran (2015\u20132017): superiority of 21-plex PCR over the Vitek 2 system for yeast identification","volume":"69","author":"Kord","year":"2020","journal-title":"J Med Microbiol"},{"key":"2021050323561757500_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fcimb.2019.00021","article-title":"Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA sequencing for a wide range of clinically isolated yeast species: improved identification by combining 21-Plex PCR and API 20C AUX as an alternative strategy for developing countries","volume":"9","author":"Arastehfar","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2021050323561757500_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3767\/003158515X689135","article-title":"One fungus, which genes? Development and assessment of universal primers for potential secondary fungal DNA barcodes","volume":"35","author":"Stielow","year":"2015","journal-title":"Persoonia"},{"key":"2021050323561757500_bib17","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: fourth edition","author":"Clinical and Laboratory Standards Institute","year":"2017"},{"key":"2021050323561757500_bib18","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021050323561757500_bib19","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of Caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050323561757500_bib20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/mmy\/myy148","article-title":"Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases","volume":"57","author":"Arastehfar","year":"2019","journal-title":"Med Mycol"},{"key":"2021050323561757500_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/fmb-2018-0253","article-title":"First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility","volume":"14","author":"Arastehfar","year":"2019","journal-title":"Future Microbiol"},{"key":"2021050323561757500_bib22","doi-asserted-by":"crossref","first-page":"e02503","DOI":"10.1128\/AAC.02503-18","article-title":"Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential prognostic values of genotyping and sequencing of PDR1","volume":"63","author":"Arastehfar","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050323561757500_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myz124","article-title":"Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates","author":"Arastehfar","year":"2020","journal-title":"Med Mycol"},{"key":"2021050323561757500_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diagmicrobio.2019.05.017","article-title":"Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea","volume":"95","author":"Ko","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021050323561757500_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11046-010-9388-0","article-title":"Antifungal susceptibility of bloodstream Candida isolates in Sfax Hospital: Tunisia","volume":"171","author":"Sellami","year":"2011","journal-title":"Mycopathologia"},{"key":"2021050323561757500_bib26","first-page":"\u2013","article-title":"Clinical and microbiological factors associated with mortality in candidemia in adult patients 2007","volume":"51","author":"Ala-Houhala","year":"2019","journal-title":"Infect Dis (London)"},{"key":"2021050323561757500_bib27","doi-asserted-by":"crossref","first-page":"e01564","DOI":"10.1128\/JCM.01564-17","article-title":"Update from a 12-year nationwide fungemia surveillance: increasing intrinsic and acquired resistance causes concern","volume":"56","author":"Astvad","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2021050323561757500_bib28","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/s41598-019-40280-8","article-title":"Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia","volume":"9","author":"Lindberg","year":"2019","journal-title":"Sci Rep"},{"key":"2021050323561757500_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","article-title":"Twenty-two years of candidaemia surveillance: results from a Norwegian national study","volume":"21","author":"Hesstvedt","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2021050323561757500_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","article-title":"Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study","volume":"6","author":"Leroy","year":"2016","journal-title":"Ann Intensive Care"},{"key":"2021050323561757500_bib31","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"Lockhart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021050323561757500_bib32","first-page":"14","article-title":"Epidemiology of candidemia at a tertiary Canadian hospital, 2004\u20132013","volume":"3","author":"Remington","year":"2018","journal-title":"Can Med Microbiol Infect Dis"},{"key":"2021050323561757500_bib33","doi-asserted-by":"crossref","first-page":"1103\u20131108","DOI":"10.1093\/jac\/dkx047","article-title":"Changing epidemiology of candidaemia in Australia","volume":"72","author":"Chapman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021050323561757500_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jgar.2019.04.003","article-title":"First multicentre report of in vitro resistance rates in candidaemia isolates in Turkey","volume":"18","author":"Arikan-Akdagli","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"2021050323561757500_bib35","doi-asserted-by":"crossref","first-page":"e216250","DOI":"10.1371\/journal.pone.0216250","article-title":"Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait","volume":"14","author":"Khan","year":"2019","journal-title":"PLoS One"},{"key":"2021050323561757500_bib36","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/jac\/dkt083","article-title":"Invasive candidiasis in intensive care units in China: a multicentre prospective observational study","volume":"68","author":"Guo","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2021050323561757500_bib37","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.3314\/mmj.17-00014","article-title":"National trends in the Japanese distribution of major Candida species causing candidemia during 2003\u20132014","volume":"59","author":"Kakeya","year":"2018","journal-title":"Med Mycol J"},{"key":"2021050323561757500_bib38","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1038\/emi.2017.74","article-title":"Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients","volume":"6","author":"Wu","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"2021050323561757500_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jiac.2018.09.016","article-title":"Changing epidemiology of non-albicans candidemia in Korea","volume":"25","author":"Ko","year":"2019","journal-title":"J Infect Chemother"},{"key":"2021050323561757500_bib40","doi-asserted-by":"crossref","first-page":"e0118770","DOI":"10.1371\/journal.pone.0118770","article-title":"Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage","volume":"10","author":"Won","year":"2015","journal-title":"PLoS One"},{"key":"2021050323561757500_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jmii.2013.08.017","article-title":"Changing epidemiology of candidemia in a medical center in middle Taiwan","volume":"48","author":"Hii","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"2021050323561757500_bib42","doi-asserted-by":"crossref","first-page":"e00153","DOI":"10.1128\/AAC.00153-18","article-title":"Profiling of PDR1 and MSH2 in Candida glabrata bloodstream isolates from a multicenter study in China","volume":"62","author":"Hou","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050323561757500_bib43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fcimb.2019.00264","article-title":"Molecular identification, genotypic diversity, antifungal susceptibility, and clinical outcomes of infections caused by clinically underrated yeasts, Candida orthopsilosis, and Candida metapsilosis: An Iranian multicenter study (2014\u20132019)","volume":"9","author":"Arastehfar","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2021050323561757500_bib44","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/5\/422\/37168701\/myaa059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/5\/422\/37168701\/myaa059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T22:26:34Z","timestamp":1667427994000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/5\/422\/5874571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,7,21]]},"published-print":{"date-parts":[[2021,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaa059","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2020,7,21]]}}}